by Keishi Foecke | Oct 22, 2025 | Blog Post
Recent commentary from senior Federal Trade Commission (FTC) and Department of Justice (DOJ) officials signaled a continued commitment to activist antitrust enforcement – compounding the uncertainty for thousands of small and early-state life science companies that...
by Keishi Foecke | Oct 9, 2025 | Blog Post
In a recent study published in Concurrences Law & Economics, Cornerstone Research experts found a significant association between biopharmaceutical mergers and acquisitions (M&A) and the likelihood of new and novel therapies coming to market. After analyzing...
by Keishi Foecke | Sep 30, 2025 | PULSE Partner
In this guest blog, Kristin Jones, CEO of PULSE Partner Indiana Life Sciences Association, discusses how pro-competitive mergers and acquisitions (M&A) have played a crucial role in supporting collaborations between universities, academic researchers and life...
by Keishi Foecke | Sep 4, 2025 | Blog Post
Following a recent Trump Administration executive order, the Federal Trade Commission (FTC) and Department of Justice (DOJ) both released statements signaling a shift to a more balanced approach to mergers and acquisitions (M&A)...
by Keishi Foecke | Aug 28, 2025 | Blog Post
Investment in early-stage life sciences companies is critical to sustain America’s global leadership in discovering and developing new medical breakthroughs for patients, according to a recent General Catalyst blog, “The Future of Life Sciences Investment.”...
by Keishi Foecke | Aug 6, 2025 | Innovations Advanced by M&A
This blog is another installment in a series, Innovations Advanced by M&A, that underscores the unique role of mergers and acquisitions in promoting a competitive and innovative life sciences ecosystem for patients. You can find previous blogs in this...
by Keishi Foecke | Jul 30, 2025 | Blog Post
The Federal Trade Commission (FTC) and Department of Justice (DOJ)’s approach toward mergers and acquisitions (M&A) is obstructing a critical exit point for innovative early-stage companies, according to Vanderbilt University Law School professor Brian Broughman...
by Keishi Foecke | Jul 23, 2025 | PULSE Partner
In a recent op-ed for Deseret News, Kelvyn Cullimore, CEO of PULSE Partner BioUtah, emphasizes the importance of federal policies that support pro-competitive life sciences mergers and acquisitions (M&A), in order to sustain innovation and growth in the life...
by Keishi Foecke | Jul 16, 2025 | Blog Post
Over the last several months, PULSE and its network of nearly 40 partners have continued to build awareness of the unique and fundamental role of life sciences mergers and acquisitions (M&A). Read below for a round-up of recent PULSE updates and commentaries....
by Keishi Foecke | Jun 26, 2025 | Blog Post, Innovations Advanced by M&A
This blog is another installment in a series, Innovations Advanced by M&A, that underscores the unique role of mergers and acquisitions in promoting a competitive and innovation life sciences ecosystem for patients. You can find previous blogs in this series here....
